New England Journal of Medicine最新文献

筛选
英文 中文
Progress toward Mitigating Disability Progression in Multiple Sclerosis. 缓解多发性硬化症残疾进展的进展。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-15 DOI: 10.1056/nejme2503891
Peter A Calabresi
{"title":"Progress toward Mitigating Disability Progression in Multiple Sclerosis.","authors":"Peter A Calabresi","doi":"10.1056/nejme2503891","DOIUrl":"https://doi.org/10.1056/nejme2503891","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"44 1","pages":"1966-1968"},"PeriodicalIF":158.5,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ph-Positive Acute Lymphoblastic Leukemia - 25 Years of Progress. ph阳性急性淋巴细胞白血病- 25年的进展。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-15 DOI: 10.1056/nejmra2405573
Robin Foà
{"title":"Ph-Positive Acute Lymphoblastic Leukemia - 25 Years of Progress.","authors":"Robin Foà","doi":"10.1056/nejmra2405573","DOIUrl":"https://doi.org/10.1056/nejmra2405573","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"40 1","pages":"1941-1952"},"PeriodicalIF":158.5,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Longitudinal Changes in Airway Mucus Plugs and FEV1 in COPD. COPD患者气道粘液塞和FEV1的纵向变化。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-15 DOI: 10.1056/NEJMc2502456
Sofia K Mettler, Pietro Nardelli, Monica Iturrioz Campo, Rubén San José Estépar, Padma P Manapragada, Mostafa Abozeed, Muhammad Usman Aziz, Mohd Zahid, Scott Grumley, Hrudaya P Nath, Andrew Yen, Sushilkumar Sonavane, Christian F Clarenbach, Wei Wang, Carrie L Pistenmaa, George R Washko, Raúl San José Estépar, Michael H Cho, Alejandro A Diaz
{"title":"Longitudinal Changes in Airway Mucus Plugs and FEV<sub>1</sub> in COPD.","authors":"Sofia K Mettler, Pietro Nardelli, Monica Iturrioz Campo, Rubén San José Estépar, Padma P Manapragada, Mostafa Abozeed, Muhammad Usman Aziz, Mohd Zahid, Scott Grumley, Hrudaya P Nath, Andrew Yen, Sushilkumar Sonavane, Christian F Clarenbach, Wei Wang, Carrie L Pistenmaa, George R Washko, Raúl San José Estépar, Michael H Cho, Alejandro A Diaz","doi":"10.1056/NEJMc2502456","DOIUrl":"https://doi.org/10.1056/NEJMc2502456","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"392 19","pages":"1973-1975"},"PeriodicalIF":96.2,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144081713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Xenotransplantation - Long Awaited, Much Learned, Much More to Be Learned. 异种移植-期待已久,学得多,还有待学习。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-15 DOI: 10.1056/nejme2504399
Sandy Feng
{"title":"Xenotransplantation - Long Awaited, Much Learned, Much More to Be Learned.","authors":"Sandy Feng","doi":"10.1056/nejme2504399","DOIUrl":"https://doi.org/10.1056/nejme2504399","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"57 1","pages":"1971-1972"},"PeriodicalIF":158.5,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Torsion of a Mature Cystic Ovarian Teratoma. 成熟卵巢囊肿畸胎瘤扭转。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-15 DOI: 10.1056/nejmicm2415320
Xiaodong Zhang,Peng Xie
{"title":"Torsion of a Mature Cystic Ovarian Teratoma.","authors":"Xiaodong Zhang,Peng Xie","doi":"10.1056/nejmicm2415320","DOIUrl":"https://doi.org/10.1056/nejmicm2415320","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"14 1","pages":"e45"},"PeriodicalIF":158.5,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Driving Jackson. 杰克逊驾驶。
IF 96.2 1区 医学
New England Journal of Medicine Pub Date : 2025-05-15 Epub Date: 2025-05-10 DOI: 10.1056/NEJMp2414963
Rajeev Raghavan
{"title":"Driving Jackson.","authors":"Rajeev Raghavan","doi":"10.1056/NEJMp2414963","DOIUrl":"10.1056/NEJMp2414963","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":" ","pages":"1879-1881"},"PeriodicalIF":96.2,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144041355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries. 医疗保险受益人中补贴药品覆盖面的损失和死亡率。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-14 DOI: 10.1056/nejmsa2414435
Eric T Roberts,Jessica Phelan,Aaron L Schwartz,Ellen Meara,Dominic Ruggiero,Lilly Estenson,Rachel M Werner,José F Figueroa
{"title":"Loss of Subsidized Drug Coverage and Mortality among Medicare Beneficiaries.","authors":"Eric T Roberts,Jessica Phelan,Aaron L Schwartz,Ellen Meara,Dominic Ruggiero,Lilly Estenson,Rachel M Werner,José F Figueroa","doi":"10.1056/nejmsa2414435","DOIUrl":"https://doi.org/10.1056/nejmsa2414435","url":null,"abstract":"BACKGROUNDA total of 14 million Medicare beneficiaries receive the Low-Income Subsidy (LIS), which reduces cost sharing in Medicare Part D. Losing the LIS may impede medication access and affect mortality.METHODSUsing 2015-2023 Medicare data, we identified dual-eligible Medicare-Medicaid beneficiaries, who automatically receive the LIS, and calculated annual rates of Medicaid and LIS loss. To examine the relationship between LIS loss and mortality, we leveraged a natural experiment arising from the relationship between the timing of Medicaid disenrollment and subsequent LIS loss. We compared beneficiaries disenrolling from Medicaid in January through June, who kept the LIS through December (6 to 11 additional months), with those disenrolling in July through December, who kept the LIS through the following December (12 to 17 additional months). Among persons disenrolling from Medicaid during 2015-2017, we examined cumulative mortality 7 to 17 months after disenrollment, when those with earlier disenrollment were more likely to lose the LIS.RESULTSThe sample included 969,606 persons with early (January though June) Medicaid disenrollment and 920,158 with late (July though December) Medicaid disenrollment. Those with early Medicaid disenrollment averaged 13.6 cumulative months of the LIS in the 17 months after disenrollment, as compared with 15.3 months for those with late disenrollment. At 17 months after Medicaid disenrollment, cumulative mortality was higher among persons with early disenrollment (78.3 per 1000) than among those with late disenrollment (75.3 per 1000), a difference of 3.0 deaths per 1000 (95% confidence interval [CI], 2.1 to 3.9). Mortality differences between persons with early disenrollment and those with late disenrollment were amplified among those in the highest quintile of baseline Part D spending (5.6 deaths per 1000; 95% CI, 3.3 to 7.9) and users of medications for cardiovascular disease, chronic lung disease, or human immunodeficiency virus infection.CONCLUSIONSLoss of drug subsidies after Medicaid disenrollment was associated with higher mortality among low-income Medicare beneficiaries. (Funded by the National Institute on Aging and others.).","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"32 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143982482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. 替西帕肽与西马鲁肽治疗肥胖症的比较。
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-11 DOI: 10.1056/nejmoa2416394
Louis J Aronne,Deborah Bade Horn,Carel W le Roux,Wayne Ho,Beverly L Falcon,Elisa Gomez Valderas,Sagar Das,Clare J Lee,Leonard C Glass,Cagri Senyucel,Julia P Dunn,
{"title":"Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.","authors":"Louis J Aronne,Deborah Bade Horn,Carel W le Roux,Wayne Ho,Beverly L Falcon,Elisa Gomez Valderas,Sagar Das,Clare J Lee,Leonard C Glass,Cagri Senyucel,Julia P Dunn,","doi":"10.1056/nejmoa2416394","DOIUrl":"https://doi.org/10.1056/nejmoa2416394","url":null,"abstract":"BACKGROUNDTirzepatide and semaglutide are highly effective medications for obesity management. The efficacy and safety of tirzepatide as compared with semaglutide in adults with obesity but without type 2 diabetes is unknown.METHODSIn this phase 3b, open-label, controlled trial, adult participants with obesity but without type 2 diabetes were randomly assigned in a 1:1 ratio to receive the maximum tolerated dose of tirzepatide (10 mg or 15 mg) or the maximum tolerated dose of semaglutide (1.7 mg or 2.4 mg) subcutaneously once weekly for 72 weeks. The primary end point was the percent change in weight from baseline to week 72. Key secondary end points included weight reductions of at least 10%, 15%, 20%, and 25% and a change in waist circumference from baseline to week 72.RESULTSA total of 751 participants underwent randomization. The least-squares mean percent change in weight at week 72 was -20.2% (95% confidence interval [CI], -21.4 to -19.1) with tirzepatide and -13.7% (95% CI, -14.9 to -12.6) with semaglutide (P<0.001). The least-squares mean change in waist circumference was -18.4 cm (95% CI, -19.6 to -17.2) with tirzepatide and -13.0 cm (95% CI, -14.3 to -11.7) with semaglutide (P<0.001). Participants in the tirzepatide group were more likely than those in the semaglutide group to have weight reductions of at least 10%, 15%, 20%, and 25%. The most common adverse events in both treatment groups were gastrointestinal, and most were mild to moderate in severity and occurred primarily during dose escalation.CONCLUSIONSAmong participants with obesity but without diabetes, treatment with tirzepatide was superior to treatment with semaglutide with respect to reduction in body weight and waist circumference at week 72. (Funded by Eli Lilly; SURMOUNT-5 ClinicalTrials.gov number, NCT05822830.).","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"44 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2025-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143932985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-Driven Clinical Documentation - Driving Out the Chitchat? 人工智能驱动的临床文件-驱逐闲聊?
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-10 DOI: 10.1056/nejmp2416064
Gordon D Schiff
{"title":"AI-Driven Clinical Documentation - Driving Out the Chitchat?","authors":"Gordon D Schiff","doi":"10.1056/nejmp2416064","DOIUrl":"https://doi.org/10.1056/nejmp2416064","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"35 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143932986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sixty Years of Community Health Centers - An Anniversary at a Crossroads. 社区卫生中心60年——十字路口的周年纪念
IF 158.5 1区 医学
New England Journal of Medicine Pub Date : 2025-05-10 DOI: 10.1056/nejmp2416468
Alexander E Jacobs
{"title":"Sixty Years of Community Health Centers - An Anniversary at a Crossroads.","authors":"Alexander E Jacobs","doi":"10.1056/nejmp2416468","DOIUrl":"https://doi.org/10.1056/nejmp2416468","url":null,"abstract":"","PeriodicalId":54725,"journal":{"name":"New England Journal of Medicine","volume":"1 1","pages":""},"PeriodicalIF":158.5,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143932988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信